CBD Powder 6%
water-soluble
CBD Powder 6% is a flavorless intermediate optimizing your CBD containing product solutions. Innovative technology is paired with long-term experience in professional powder formulation. The result is an easy-to-mix powder enabling immediate processing for your product refinement. Beyond any need of oil base, CBD Powder 6% is ready for direct mixing in versatile solutions. Consumer solutions range from solida to water-based products.
More product solutions
Your benefits
CBD Powder 6% offers unique B2B opportunities for product refinement and development. The novel formulation allows fast and easy boost of your portfolio, enabling a fast market entry.
Consumer benefits:
- Flavorless, mild taste
- 0.0% THC
B2B:
- Portfolio-booster effect: easy product refinement
- Enabling fast and efficient product development
- Easy to process in food, feed, cosmetics
- High Scalability
- Produced under FSSC, Certified batch product
- CBD from EU, manufacturing in Germany
- 0.0% THC simplifies import/export and market access
Product consultation
Product specifications
granular form
CHARACTERS
Test / Assay | Method | Specification |
Appearance | visually | white-yellowish to pink violet tint granules |
PHYSICAL and CHEMICAL SPECIFICATIONS
Test / Assay | Method | Specification |
CBD content | HPLC | ≥ 5.4 % |
THC content | Manufacturer CFA | ≤ 0.2 % |
Minor cannabinoid impurities (CBDa, CBDV, CBN, CBGa, CBG, CBC) | Manufacturer CFA | ≤ 0.32 % (individual compounds) |
Bulk density | Ph. Eur. 2.9.34,
Method 3 (ISO 697) |
600 g/L – 750 g/L |
Loss Of Drying (LOD) | IR moisture balance | ≤ 4.0 % |
BIOLOGICAL SPECIFICATIONS
Parameter | Unit | Guide value | Warning value |
Aerobic mesophilic bacterial count
method: § 64 LFGB L 00.00-88-1:2023-04 (equals ISO 4833-1) |
KbE/g | 10.000 | – |
Enterobacteriaceae
method: § 64 LFGB L 00.00-133/2:2019-12 (equals ISO 21528-2) |
KbE/g | 100 | 1.000 |
Escherichia coli
method: § 64 LFGB L 00.00-132/2:2010-09 (equals ISO 16649-2) |
KbE/g | 10 | 100 |
Coagulase-positive staphylococci
method: § 64 LFGB L 00.00-56:2004-12 (equals ISO 6888-2) |
KbE/g | 10 | 100 |
Presumptive Bacillus cereus
method: BAV-IM-5.4-12-01:2019-10 (validated against ISO 7932) |
KbE/g | 100 | 1.000 |
Mold
method: ISO 21527-2:2008-07 |
KbE/g | 100 | – |
Salmonella spp.
method: BAV-IM-5.4-09-01:2020-05 (validated against ISO 6579) |
1/25g | nd |
nd = not detectable
More products
Other visitors also were interested in these products:
FDA DISCLAIMER The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.